Gates strengthens commitment to European R&D

MicrosoftMicrosoft Chairman Bill Gates aired his opinions on innovation in Europe and renewed his commitment to working with European partners at the recent Microsoft Innovation Day in Brussels.

"The Lisbon agenda was very ambitious, with the goal of getting R&D [research and development] to 3%, looking at how the top universities can get the right R&D funding, and the increase in funding for a broad set of research activities, we are very excited to see that," he said in his keynote address. "We think that this is pushing things in the right direction, so that Europe can get its share of these great advances and participate in a very, very strong way."

Microsoft already invests heavily in research in Europe, and the company recently opened a new R&D centre in Portugal and has extended its cooperation with leading computer science centres in several European universities. Microsoft's research centres are also active in a number of European research projects, something which Mr Gates describes as having worked out very well for the company.

"We try and be an example, a real evangelist for companies in industry and research," Mr Gates commented. "We think that that has been our very best investment. The reason we have got a strong future is because we did that research."

Attending the event, Finnish Prime Minister Matti Vanhanen noted that innovation was a major priority for his country's presidency of the EU. "Innovation is high on our political agenda, both for Finland and for the EU," he commented. "My close personal involvement as Prime Minister sends a strong signal that innovation and development of the information society are important priorities for the government and for the state."

Mr Vanhanen encouraged companies to get involved in joint research platforms, noting that these could be eligible for funding under the Seventh Framework Programme (FP7) as Joint Technology Initiatives (JTIs).

"They [JTIs] are a practical new way of improving our research performance and driving the whole process more from the private sector, which has been one great weakness in European innovation policy until now," he said. "With technology platforms, it is companies, not civil servants or committees, that identify promising areas."

European Research Commissioner Janez Potocnik also attended the event, and delivered a speech on information and communications technologies (ICT). "For me, ICTs are about empowerment," he said. "Noting that with ICTs, people could find information at the click of a button, communicate from anywhere and project their own ideas and values."

According to the Commissioner, ICT is a field of research that can teach us quite a few good lessons for research overall. "It shows that technology can be an enabler, promoting and aiding developments in a wide range of fields," he said.

"The ICT sector shows the value in investing in long-term, frontier research... What the ICT sector also teaches us is that a long term vision should be about providing society with research that corresponds to its needs," he added.

For further information, please visit:
http://www.euinnovationday.com/

Related news articles:

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...